72
Participants
Start Date
October 1, 2024
Primary Completion Date
June 1, 2026
Study Completion Date
December 1, 2026
Dexmedetomidine
DEX 4 mcg/100 ml at a starting dose of 0.6 mcg/kg/hour and increased by 0.2 mcg/kg/hour every 30 minutes up to final dose of 1.4 mcg/kg/hour.
Placebo
NaCl 0.9% 100ml
Canadian Critical Care Trials Group
OTHER
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
OTHER